Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IKT Inhibikase Therapeutics, Inc.

交易中 11-05 12:37:43 EST

2.67

+0.06

+2.30%

最高2.71	最低2.61	成交量5.97万
今开2.62	昨收2.61	日振幅3.83%
总市值1.79亿	流通市值1.79亿	总股本6,719万
成交额15.91万	换手率0.09%	流通股本6,719万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IKT","market":"US","secType":"STK","nameCN":"Inhibikase Therapeutics, Inc.","latestPrice":2.67,"timestamp":1730827918832,"preClose":2.61,"halted":0,"volume":59726,"delay":0,"floatShares":67192570,"shares":67192570,"eps":-3.136369,"marketStatus":"交易中","marketStatusCode":2,"change":0.06,"latestTime":"11-05 12:37:43 EST","open":2.62,"high":2.71,"low":2.61,"amount":159108.0452612,"amplitude":0.038314,"askPrice":2.69,"askSize":100,"bidPrice":2.65,"bidSize":24,"shortable":3,"etf":0,"ttmEps":-3.136369,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1730840400000},"adr":0,"listingDate":1608699600000,"adjPreClose":2.61,"postHourTrading":{"tag":"盘后","latestPrice":2.66,"preClose":2.61,"latestTime":"18:05 EST","volume":923,"amount":2427.35,"timestamp":1730761517991},"volumeRatio":0.62503},"requestUrl":"/m/hq/s/IKT","defaultTab":"news","newsList":[{"id":"2480058472","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480058472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480058472?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:52","pubTimestamp":1730731944,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时52分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速下跌5.30%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225224971a42c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225224971a42c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IKT","LENZ"],"gpt_icon":0},{"id":"2479203347","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘快速下挫5.74%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479203347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479203347?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:56","pubTimestamp":1730382997,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时56分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速下挫5.74%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.37%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215637a2023873&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215637a2023873&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","IKT"],"gpt_icon":0},{"id":"2479025810","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479025810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479025810?lang=zh_cn&edition=full","pubTime":"2024-10-30 02:36","pubTimestamp":1730226985,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日02时36分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速下挫5.11%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030023625971a2fec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030023625971a2fec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2478486730","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大涨6.73%报2.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478486730","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478486730?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:47","pubTimestamp":1730123273,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时47分，Inhibikase Therapeutics, Inc.股票出现波动，股价急速拉升6.73%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214753a1f25614&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214753a1f25614&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IKT","BK4139"],"gpt_icon":0},{"id":"2478493993","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘大幅跳水5.95%报2.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478493993","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478493993?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:11","pubTimestamp":1729865467,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日22时11分，Inhibikase Therapeutics, Inc.股票出现波动，股价急速跳水5.95%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025221107971a2575&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025221107971a2575&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2477538213","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘股价大涨5.21%报2.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477538213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477538213?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:31","pubTimestamp":1729690274,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时31分，Inhibikase Therapeutics, Inc.股票出现异动，股价大幅上涨5.21%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023213114ab6d6e37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023213114ab6d6e37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IKT","LENZ"],"gpt_icon":0},{"id":"2477808337","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘股价大跌7.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477808337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477808337?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:32","pubTimestamp":1729603948,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时32分，Inhibikase Therapeutics, Inc.股票出现波动，股价大幅下挫7.66%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221322895bb6ca8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221322895bb6ca8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2477986300","title":"Inhibikase Therapeutics, Inc.盘中异动 大幅上涨6.57%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477986300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477986300?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:30","pubTimestamp":1729517457,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时30分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速上涨6.57%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213058a1e24921&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213058a1e24921&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2476255113","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大跌7.23%报2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476255113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476255113?lang=zh_cn&edition=full","pubTime":"2024-10-18 21:40","pubTimestamp":1729258811,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日21时40分，Inhibikase Therapeutics, Inc.股票出现异动，股价大幅下挫7.23%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018214011ab6b2ece&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018214011ab6b2ece&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","IKT"],"gpt_icon":0},{"id":"2476736121","title":"Inhibikase Therapeutics, Inc.盘中异动 急速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476736121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476736121?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:56","pubTimestamp":1729173367,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时56分，Inhibikase Therapeutics, Inc.股票出现波动，股价大幅拉升5.15%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017215608ab6ad922&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017215608ab6ad922&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","IKT"],"gpt_icon":0},{"id":"2475899064","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大涨6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475899064","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475899064?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:41","pubTimestamp":1729086075,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时41分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速上涨6.43%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016214115ab6a8eb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016214115ab6a8eb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IKT","LENZ"],"gpt_icon":0},{"id":"2475439970","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘快速上涨5.31%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475439970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475439970?lang=zh_cn&edition=full","pubTime":"2024-10-14 23:13","pubTimestamp":1728918791,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日23时13分，Inhibikase Therapeutics, Inc.股票出现波动，股价急速拉升5.31%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014231312a1e0911c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014231312a1e0911c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IKT","LENZ"],"gpt_icon":0},{"id":"2474097880","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘快速上涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474097880","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474097880?lang=zh_cn&edition=full","pubTime":"2024-10-11 22:05","pubTimestamp":1728655515,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日22时05分，Inhibikase Therapeutics, Inc.股票出现异动，股价大幅上涨5.38%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011220516a1e003cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011220516a1e003cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IKT","BK4139"],"gpt_icon":0},{"id":"2474749053","title":"Inhibikase Therapeutics, Inc.盘中异动 快速拉升6.35%报1.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474749053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474749053?lang=zh_cn&edition=full","pubTime":"2024-10-10 21:30","pubTimestamp":1728567047,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日21时30分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速上涨6.35%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010213047ab6928e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010213047ab6928e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IKT","LENZ"],"gpt_icon":0},{"id":"2474820391","title":"Cellectar Biosciences, Inc.盘中异动 下午盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474820391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474820391?lang=zh_cn&edition=full","pubTime":"2024-10-10 03:07","pubTimestamp":1728500850,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日03时07分，Cellectar Biosciences, Inc.股票出现波动，股价大幅跳水5.08%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Nutriband Inc C/Wts 、Apollomics Inc C/Wts 01/04/2028 、Inhibikase Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Inhibikase Therapeutics, Inc.较为活跃，换手率分别为726.64%、573.06%、250.04%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Inhibikase Therapeutics, Inc.，振幅分别为108.00%、73.66%、64.70%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101003073198e3b862&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101003073198e3b862&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IKT","CLRB"],"gpt_icon":0},{"id":"2474271388","title":"Traws Pharma, Inc.盘中异动 下午盘股价大跌5.00%报4.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474271388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474271388?lang=zh_cn&edition=full","pubTime":"2024-10-10 01:04","pubTimestamp":1728493448,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日01时04分，Traws Pharma, Inc.股票出现异动，股价快速跳水5.00%。截至发稿，该股报4.56美元/股，成交量3992股，换手率0.13%，振幅2.87%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101001040898e3b834&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101001040898e3b834&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","TRAW","BK4007","BK4139"],"gpt_icon":0},{"id":"2474276162","title":"Skye Bioscience, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474276162","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474276162?lang=zh_cn&edition=full","pubTime":"2024-10-10 00:25","pubTimestamp":1728491148,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日00时25分，Skye Bioscience, Inc.股票出现波动，股价大幅跳水5.04%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Inhibikase Therapeutics, Inc.、Kezar Life Sciences, Inc.涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Inhibikase Therapeutics, Inc.较为活跃，换手率分别为708.70%、452.62%、226.46%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Inhibikase Therapeutics, Inc.、Cue Biopharma, Inc.，振幅分别为108.00%、45.37%、39.02%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010002548ab68e319&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010002548ab68e319&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139","IKT"],"gpt_icon":0},{"id":"2474273999","title":"Cardio Diagnostics Holdings Inc.盘中异动 股价大跌5.04%报0.202美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474273999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474273999?lang=zh_cn&edition=full","pubTime":"2024-10-10 00:04","pubTimestamp":1728489851,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日00时04分，Cardio Diagnostics Holdings Inc.股票出现异动，股价快速下挫5.04%。截至发稿，该股报0.202美元/股，成交量45.8761万股，换手率1.91%，振幅6.45%。Cardio Diagnostics Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Cardio Diagnostics Holdings Inc.公司简介：Cardio Diagnostics Holdings Inc 是一家生物技术公司，致力于使心血管疾病的预防和早期检测更加便捷、个性化和精确。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410100004129719f4ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410100004129719f4ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDIO","IKT","BK4139"],"gpt_icon":0},{"id":"2474310273","title":"Rocket Pharmaceuticals Inc C/Wts 02/09/2026 (To Pur Com)股价重挫17.80% 市值跌806.89万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474310273","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474310273?lang=zh_cn&edition=full","pubTime":"2024-10-09 23:47","pubTimestamp":1728488821,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日23时47分，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 股票出现异动，股价快速下跌17.80%。Rocket Pharmaceuticals Inc C/Wts 02/09/2026 股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Inhibikase Therapeutics, Inc.、Kezar Life Sciences, Inc.涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Inhibikase Therapeutics, Inc.较为活跃，换手率分别为692.05%、427.67%、214.13%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Inhibikase Therapeutics, Inc.、Cue Biopharma, Inc.，振幅分别为108.00%、45.37%、39.02%。Rocket Pharmaceuticals Inc C/Wts 02/09/2026 公司简介：Rocket Pharmaceuticals Inc 是一家后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009234701959b30a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009234701959b30a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKTW","BK4139","IKT"],"gpt_icon":0},{"id":"2474278339","title":"Biodexa Pharmaceuticals Plc盘中异动 早盘大幅下挫5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474278339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474278339?lang=zh_cn&edition=full","pubTime":"2024-10-09 23:21","pubTimestamp":1728487315,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日23时21分，Biodexa Pharmaceuticals Plc股票出现波动，股价大幅跳水5.52%。截至发稿，该股报5.31美元/股，成交量1.1442万股，换手率1.97%，振幅8.90%。Biodexa Pharmaceuticals Plc股票所在的生物技术行业中，整体跌幅为0.17%。Biodexa Pharmaceuticals Plc公司简介：Biodexa Pharmaceuticals PLC是一家药物输送技术公司，专注于改善药物的生物输送和生物分配。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009232156ab68e122&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009232156ab68e122&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IKT","BDRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inhibikase.com","stockEarnings":[{"period":"1week","weight":-0.0474},{"period":"1month","weight":1.0714},{"period":"3month","weight":0.9924},{"period":"6month","weight":0.8643},{"period":"1year","weight":1.534},{"period":"ytd","weight":1.0551}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inhibikase Therapeutics, Inc.于2010年6月3日注册为特拉华州公司。该公司是一家临床阶段制药公司，致力于开发针对帕金森氏病或PD以及大脑内外发生的相关疾病的疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.425952},{"month":2,"riseRate":0.5,"avgChangeRate":-0.118451},{"month":3,"riseRate":0.25,"avgChangeRate":0.045803},{"month":4,"riseRate":0,"avgChangeRate":-0.217435},{"month":5,"riseRate":0.75,"avgChangeRate":0.088455},{"month":6,"riseRate":0,"avgChangeRate":-0.283409},{"month":7,"riseRate":0.5,"avgChangeRate":-0.045361},{"month":8,"riseRate":0.5,"avgChangeRate":-0.009087},{"month":9,"riseRate":0,"avgChangeRate":-0.157472},{"month":10,"riseRate":0.5,"avgChangeRate":0.119822},{"month":11,"riseRate":0.75,"avgChangeRate":-0.030283},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.028053}],"exchange":"NASDAQ","name":"Inhibikase Therapeutics, Inc.","nameEN":"Inhibikase Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inhibikase Therapeutics, Inc.(IKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inhibikase Therapeutics, Inc.,IKT,Inhibikase Therapeutics, Inc.股票,Inhibikase Therapeutics, Inc.股票老虎,Inhibikase Therapeutics, Inc.股票老虎国际,Inhibikase Therapeutics, Inc.行情,Inhibikase Therapeutics, Inc.股票行情,Inhibikase Therapeutics, Inc.股价,Inhibikase Therapeutics, Inc.股市,Inhibikase Therapeutics, Inc.股票价格,Inhibikase Therapeutics, Inc.股票交易,Inhibikase Therapeutics, Inc.股票购买,Inhibikase Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inhibikase Therapeutics, Inc.(IKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}